Physical Address
Indirizzo: Via Mario Greco 60, Buttigliera Alta, 10090, Torino, Italy
The anticancers are available, with the guarantee of access to treatment for each patient, in due time and without interruption. This was indicated by the central pharmacy of hospitals (PCH) in a statement published on Thursday by the Ministry of Health.
Social networks have been rustling for a few days of alarming rumors on a supposed rupture of supply of anticancer drugs in hospitals. Information widely shared, but that the PCH denies forcefully.
The public institution is categorical by affirming that “no case of shortage has been recorded”. On the contrary, she said that the availability rate of these vital treatments currently exceeds 93% nationally.
The PCH also underlined its commitment to provide, “in due time and without interruption”, the drugs necessary for all patients followed in hospital structures. To guarantee this mission, it is based on an unprecedented digital device, in this case an electronic platform linked directly to hospitals. This system makes it possible to know, in real time, the levels of stock, to anticipate the needs and to coordinate the supply with the different actors of the logistics chain. She explained: “This organization allows us to quickly respond to any variation in demand, so that no patient is deprived of its treatment. »»
To illustrate the priority given to this question, the institution highlighted “a record historical budget of 84 billion dinars” devoted to the acquisition of drugs in 2025, the most important in its history. A substantial part of this envelope is intended for anticancer, but funding also covers the other medical needs of public hospitals.
In accordance with the directives of the Ministry of Health and within the framework of the Patron Action Plan (PAM), this budget makes it possible to “finance innovative drugs and to provide patients with advanced international therapeutic protocols” in order to align medical care on global standards.
The institution has recognized, however, that no system is immune to occasional difficulties, noting that certain drugs, manufactured locally or imported, may experience supply tensions during the year.
But, again, the PCH claims to have set up a strict protocol to face it through reinforced monitoring, the reorientation of stocks and the use of therapeutic substitutes validated by the health authorities.
She said: “Whatever their nature, we make every effort to ensure that these substitutes are available and meet the needs of hospitals”. And to emphasize that it “ensures to fulfill its role in accordance with the laws and regulations in force”.
For its part, the National Union of Pharmacists of Frame (SNAPO) wanted to rectify confusion. Contrary to what may have been able to circulate, the union ensures “never having made a remarks” on an alleged rupture of hospital medicines.
In a separate press release, the SNAPO said that “these words are in no way ours and cannot be assigned to us”. The union said that any official information from its body is published exclusively on its recognized communication channels.
Beyond the denial, the PCH and the SNAPO called on citizens to demonstrate discernment and not to relay undeclared information. In a context where the management of chronic diseases, and particularly cancers, mobilizes significant human and financial resources, the authorities recall that the dissemination of false information can sow concern and harm confidence between patients and health institutions.